Frequent mutation in pX region of HTLV-1 is observed in HAM/TSP patients, but is not specifically associated with the central nervous system lesions

References

• Cross S L., Feinberg M B., Wolf J B., Holbrook N J., Wong-Staal F, Leonard W J. Regulation of the human interleukin-2 receptor α chain promoter: activation of a non-functional promoter by the transactivator gene of HTLV-1. Cell 1987; 49: 47–56
   PubMed Web of Science ®Google Scholar
• Daenke S, Nightingale S, Cruickshank J K., Bangham C RM. Sequence variants of human T-cell leukemia virus type 1 from patients with tropical spastic paraparesis and adult T-cell leukemia do not distinguish neurological from leukemic isolates. J Virol 1990; 64: 1278–1282
   PubMedGoogle Scholar
• Elovaara I, Koenig S, Brewah A Y., Woods R M., Lehky T, Jacobson S. High human T cell lymphotropic virus type 1 (HTLV-1)-specific precursor cytotoxic T lymphocyte frequencies in patients with HTLV-1-associated neurological disease. J Exp Med 1993; 117: 1567–1573
   Google Scholar
• Evangelista A, Maroushek S, Minnigan H, Lerson A, Retzel E, Haase A, Gonzalez-Dunia D, McFarlin D, Mingioli E, Jacobson S, Osame M, Sonoda S. Nucleotide sequence analysis of a provirus derived from an individual with tropical spastic paraparesis. Microb Pathog 1990; 8: 259–278
   Google Scholar
• Fujii M, Sassone-Corsi P, Verma I M. c-fos promoter trans-activation by the tax 1 protein of human T-cell leukemia virus type I. Proc Natl Acad Sci USA 1988; 85: 8526–8530
   PubMed Web of Science ®Google Scholar
• Fujii M, Niki T, Matsuda M, Nomura N, Seiki M. HTLV-1 Tax induces expression of various immediate early serum responsive genes. Oncogene 1991; 6: 1023–1029
   PubMed Web of Science ®Google Scholar
• Fujisawa J, Seiki M, Kiyokawa K, Yoshida M. Functional activation of the long terminal repeat of human T-cell leukemia virus type 1 by a trans-acting factor. Proc Natl Acad Sci USA 1985; 82: 2277–2281
   PubMed Web of Science ®Google Scholar
• Furukawa Y, Fujisawa J, Osame M, Toita M, Sonoda S, Kubota R, Ijichi S, Yoshida M. Frequent clonal proliferation of human T-cell leukemia virus type 1 (HTLV-1)-infected c e 11s in HTLV-1-associated myelopathy (HAM/TSP). Blood 1992; 80: 1012–1016
   PubMed Web of Science ®Google Scholar
• Gessain A, Barin F, Vernant J C., Gout o, Maws L, Calende A, De The G. Antibodies to human Tlymphotropic virus type-1 in patients with tropical spastic paraparesis. Lancet 1985; ii: 1247–1248
   Google Scholar
• Hara H, Morita M, Iwaki T, Hatae T, Itoyama Y, Kitamoto T, Akizuki S, Goto I, Watanabe T. Detection of human T lymphotrophic virus type 1 (HTLV-1) proviral DNA and analysis of T cell receptor Vβ CDR3 sequences in spinal cord region of HTLV-1 associated myelopathy/Tropical spastic paraparesis. J Exp Med 1994; 180: 831–839
   Google Scholar
• Inoue J, Seiki M, Taniguchi T, Tsuru S, Yoshida M. Induction of interleukin 2 receptor gene expression by p40x encoded by human T-cell leukemia virus type 1. EMBO J 1986; 5: 2883–2888
   PubMed Web of Science ®Google Scholar
• Jacobson S, Shida H, McFarlin D E., Fauci A S., Koenig S. Circulating CD8+ cytotoxic T lymphocytes specific for HTLV-1 pX in patients with HTLV-1 associated neurological disease. Nature 1990; 348: 245–248
   PubMed Web of Science ®Google Scholar
• Jacobson S, McFarlin D E., Robinson S, Voskuhl R, Martin R, Brewah A, Newell A J., Koenig S. HTLV-1-specific cytotoxic T lymphocytes in the cerebrospinal fluid of patients with HTLV-1-associated neurological disease. Ann Neurol 1992; 32: 651–657
   Google Scholar
• Kannagi Shida M. H., Igarashi H, Kuruma K, Murai H, Aono Y, Maruyama I, Osame M, Hattori T, Inoko H, Harada S. Target epitope in the Tax protein of human T-cell leukemia virus type-1 recognized by class I major histocompatibility complex-restricted cytotoxic T cells. I Virol 1992; 66: 2928–2933
   Google Scholar
• Kinoshita T, Tsujimoto A, Shimotohno K. Sequence variations in LTR and env, regions of HTLV-1 do not discriminate between the virus from patients with HTLV-1-associated myelopathy and adult T-cell leukemia. Int J Cancer 1991; 47: 491–495
   PubMedGoogle Scholar
• Kira J, Koyanagi Y, Yamada T, Itoyama Y, Tateishi J, Akinrki S, Kishikawa M, Baba E, Nakamura M, Suzuki J, Nakamura T, Nakamura N, Yamamoto N, Goto I. Sequence heterogeneity of HTLV-1 proviral DNA in the central nervous system of patients with HTLV-1-associated myelopathy. Ann Neurol 1994; 36: 149–156
   Google Scholar
• Kiyokawa T, Seiki M, Iwashita S, Imagawa K, Shimizu F, Yoshida M. p27x-III and p21x-III, proteins encoded by the pX sequence of human T-cell leukemia virus type I. Proc Natl Acad Sci USA 1985; 82: 8359–8363
   PubMed Web of Science ®Google Scholar
• Komurian F, Pelloquin F, De The G. In vivogenomic variability of human T-cell leukemia virus type-1 depends more upon geography than pathologies. J Virol 1991; 65: 3770–3778
   Google Scholar
• Kubota R, Umehara F, Izumo S, Ijichi S, Matsumuro K, Yashiki S, Fujiyoshi T, Sonoda S, Osame M. HTLV-1 proviraI DNA amount correlates with infiltrating CD4 lymphocytes in the spinal cord from patients with HTLV-1 associated myelopathy. J Neuroimmunol 1994; 53: 23–29
   PubMed Web of Science ®Google Scholar
• Miyatake S, Seiki M, Malefijt R D., Heike T, Fujisawa J, Takebe Y, Nishida J, Shilomai J, Yokota T, Yoshida M, Arai K, Arai N. Activation of T cell-derived lymphokine genes in T cells and fibroblasts: effects of human T cell leukemia virus type 1 p40X protein and bovine papilloma virus encoded E2 protein. Nucleic Acids Res 1988; 16: 6547–6566
   PubMed Web of Science ®Google Scholar
• Niewiesk S, Daenke S, Parker C E., Taylor G, Weber J, Nightingale S, Bangham C RM. The transactivator gene of human T-cell leukemia virus type-1 is more variable within and between healthy carriers than patients with tropical spastic paraparesis. J Virol 1994; 68: 6778–6781
   Google Scholar
• Osame M, Usuku K, Izumo S, Ijichi N, Amitani H, Igata A, Matsumoto M, Tara M. HTLV-1 associated myelopathy, a new clinical entity. Lancet 1986; i: 1031–1032
   Google Scholar
• Osame M, Matsumoto M, Usuku K, Izumo S, Ijichi N, Amitani H, Tara M, Igata A. Chronic progressive myelopathy associated with elevated antibodies to HTLV-I and adult T-cell leukemia cells. Ann Neurol 1987; 21: 117–122
   PubMed Web of Science ®Google Scholar
• Parker E P., Nightingale S, Taylor G P., Weber J., Bangham C RM. Circulating anti-Tax cytotoxic T lymphocytes from human T-cell leukemia virus type Iinfected people, with and without tropical spastic paraparesis, recognize multiple epitopes simultaneously. J Virol 1994; 68: 2860–2868
   Google Scholar
• Poiesz B J., Ruscetti R W., Gazdar A F., Bum P A., Minna J D., Gallo R C. Detection and isolation of type C retrovirus particles from fresh and cultured lymphocytes of a patient with cutaneous T cell lymphoma. Proc Natl Acad Sci USA 1980; 77: 7415–7419
   PubMed Web of Science ®Google Scholar
• Seiki M, Hattori S, Hirayama Y, Yoshida M. Human adult T-cell leukemia virus: complete nucleotide sequence of the provirus genome integrated in leukemia cell DNA. Proc Natl Acad Sci USA 1983; 80: 3618–3622
   PubMed Web of Science ®Google Scholar
• Seiki M, Inoue J I., Takeda T, Yoshida M. Direct evidence that p4OX of human T-cell leukemia virus type I is a trans-activating transcriptional activator. EMBO J 1986; 5: 561–565
   PubMed Web of Science ®Google Scholar
• Semmes O J., Jeang K T. Mutational analysis of human T-cell leukemia virus type I Tax: Regions necessary for function determined with 47 mutant proteins. J Viral 1992; 66: 7183–7192
   PubMedGoogle Scholar
• Shirabe S, Nakamura T, Tsujihata M, Nagataki S, Seiki M, Yoshida M. Retrovirus from human T-cell leukemia virus type 1-associated myelopathy is the same strain as a prototype human T-cell leukemia virus type 1. Arch Neurol 1990; 47: 1258–1260
   PubMedGoogle Scholar
• Smith M R., Greene W C. Identification of HTLV-1 tax trans-activator mutants exhibiting novel transcription phenotypes. Genes Dev 1990; 4: 1875–1885
   PubMed Web of Science ®Google Scholar
• Sodroski J G., Rosen C A., Haseltine W A. Trans-acting transcriptional activation of the long terminal repeat of human T lymphotropic viruses in infected cells. Science 1984; 225: 381–385
   PubMed Web of Science ®Google Scholar
• Tsujimoto A, Teruuchi T, Imamura J, Shimotohno K, Miyoshi I, Miwa M. Nucleotide sequence analysis of a provirus derived from HTLV-1-associated myelopathy (HAM). Mol Biol Med 1988; 5: 24–42
   Google Scholar
• Umehara F, Izumo S, Nakagawa M, Ronquillo A T., Takahashi K, Matsumuro K, Sato E, Osame M. Immunocytochemical analysis of the infiltrate in the spinal cord lesions in HTLV-1-associated myelopathy. J Neuropathol Exp Neurol 1993; 52: 424–430
   Google Scholar
• Watanabe T. HTLV type 1 (US isolate) and ATLV (Japanese isolate) are the same species of human retrovirus. Virology 1984; 133: 238–241
   PubMed Web of Science ®Google Scholar
• Yoshida M, Miyoshi I, Hinuma Y. Isolation and characterization of retrovirus from cell lines of human adult T-cell leukemia and its implication in the disease. Proc Natl Acad Sci USA 1982; 79: 2031–2035
   PubMed Web of Science ®Google Scholar
• Yoshida M, Seiki M, Yamaguchi K, Takatsuki K. Monoclonal integration of human T-cell leukemia provirus in all primary tumours of adult T-cell leukemia suggests causative role of human T-cell leukemia virus in disease. Proc Natl Acad Sci USA 1984; 81: 2534–2537
   PubMed Web of Science ®Google Scholar
• Yoshida M, Osame M, Usuku K, Matsumoto M, Igata A. Viruses detected in HTLV-1-associated myelopathy and adult T-cell leukemia are identical on DNA blotting. Lancet 1987; i: 1085–1086
   Google Scholar
• Yoshida M, Osame M, Kawai H, Toita M, Kuwasaki N, Nishida Y, Hiraki Y, Takahashi K, Nomura K, Sonoda S, Eiraku N, Ijichi S, Usuku K. Increased replication of HTLV-1 in HTLV-1-associated myelopathy. Ann Neurol 1989; 26: 331–335
   PubMed Web of Science ®Google Scholar